Health

Results: 457-468 of 8670

PR Newswire associated0

Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference

PR Newswire associated0

Zeus Expands Access to Catheter Components Through Chamfr Marketplace

Business Wire logo

VDYNE Receives FDA Approval to Initiate the TRIVITA1 IDE Pivotal Trial of Transcatheter Tricuspid Valve Replacement System

Business Wire logo

Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer

Business Wire logo

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States

Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2

Business Wire logo

Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond

Business Wire logo

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D

PR Newswire associated0

BD Launches AI-Enabled Medication Dispensing System to the European Market

IDEXX Cancer Dx Panel with lymphoma testing

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions

PR Newswire associated0

Wegovy®▼(semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥27 kg/m2)[1]